Zobrazeno 1 - 10
of 35
pro vyhledávání: '"35"'
Autor:
G. Djokic, N. Zivkovic
Publikováno v:
European Psychiatry. 41:s809-s809
IntroductionAlthough there is no cure, schizophrenia is highly treatable disease. Successful first episode schizophrenia (FES) treatment is crucial to minimize personal, vocational and social deterioration. Quetiapine is atypical, second generation a
Autor:
Antonio Lasalvia, F. Spagnolli, Paolo Brambilla, Veronica Marinelli, Roberto Cerini, Cinzia Perlini, S. Tosato, Nicolò Cardobi, Marcella Bellani, Umberto Castellani, Letizia Squarcina, Gianluca Rambaldelli, K. De Santi, Mirella Ruggeri, Denis Peruzzo
Publikováno v:
European Psychiatry. 30:302
Introduction Vascular changes in the brain are relevant in schizophrenia [e.g. 1] and in bipolar disorder [2]. The study of first episode psychosis (FEP) allows the analysis of brain morphology and function without confounds due to chronicity. Object
Autor:
K. Nagy, György Németh, Balázs Szatmári, István Laszlovszky, M. Debelle, S. Faradzs-zade, Suresh Durgam
Publikováno v:
European Psychiatry. 30:242
Introduction Cariprazine, a dopamine D 3 /D 2 receptor partial agonist with preferential binding to D 3 receptors, is being developed for the treatment of schizophreni a Objective To explore the effect of cariprazine on negative symptoms of schizophr
Autor:
M. Opler
Publikováno v:
European Psychiatry. 25:1-1
ObjectivesThere is a need for real-time capability to detect inconsistencies in efficacy outcome measures and to predict individual-level or group-level placebo response. Training and calibration to improve reliability is one method; though this can
Publikováno v:
European Psychiatry. 23:S146
Background and Aims:To investigate delusional beliefs and their dimensions (distress, preoccupation, conviction) across three groups, including patients with schizophrenia, their healthy family members, and normal subjects.Methods:Subjects were 25 pa
Autor:
Francesca Marciello, Armida Mucci, Andrea Perrottelli, Giulia Maria Giordano, P. Pezzella, Leonardo Fazio, Silvana Galderisi, Giuseppe Blasi, Giammarco Cascino
Publikováno v:
European Psychiatry. 64:S542-S543
IntroductionNegative symptoms (NS) represent a core aspect of schizophrenia with a huge impact on real life functioning. Dysfunctions within the dopaminergic cortico-striatal circuits have been documented in subjects with schizophrenia (SCZ) and hypo
Publikováno v:
European Psychiatry. 41:S343-S344
Negative symptoms in schizophrenia, and specifically amotivation/apathy, have been correlated with impaired general functioning. Its neurobiological basis are thought to rely on an aberrant reward system. To study the association of reward deficits a
Autor:
Marta Leoni, Enrico Croce, Giulia Piazza, Silvia Costa, Luigi Grassi, S. Battista, A. Faccini, Elisabetta Recla, L. Negrelli, E. Berretti, Riccardo Dall'Olio, C. Colla, Giorgia Rossi, D. Malanchin, Rosangela Caruso, Maria Giulia Nanni
Publikováno v:
European Psychiatry. 41:S331-S332
IntroductionThe screen for cognitive impairment in psychiatry (SCIP) is a brief, accessible scale designed for detecting cognitive deficits in psychiatric disorders.ObjectivesThe objective of this study is to test the SCIP's validity as a cognitive t
Autor:
I. Halbecq, L. Segard, S. Langlois-Théry, A. Van Der Elst, Pascal Delamillieure, K. Benali, Florence Thibaut, Perrine Brazo, Michel Petit, R.M. Marié, Sonia Dollfus
Publikováno v:
European Psychiatry. 17:155-162
SummaryAimBecause of the heterogeneity of schizophrenia, this study researched different cognitive patterns in distinct subtypes of schizophrenic patients.MethodsThirty-five Diagnostic and Statistical Manual IV (DSM IV) schizophrenic patients and 35
Publikováno v:
European Psychiatry. 41:s831-s831
IntroductionSchizoaffective disorder (SAD) and schizophrenia (SZ) are important causes of disability and morbidity. Finding clinical features that can help in their early differentiation may lead to a better understanding of these two nosologic entit